Stephen Mullennix - Net Worth and Insider Trading
Stephen Mullennix Net Worth
The estimated net worth of Stephen Mullennix is at least $107,596 dollars as of 2025-05-08. Stephen Mullennix is the COO of UroGen Pharma Ltd and owns about 10,084 shares of UroGen Pharma Ltd (URGN) stock worth over $107,596. Details can be seen in Stephen Mullennix's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen Mullennix has not made any transactions after 2020-04-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen Mullennix
Stephen Mullennix Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen Mullennix owns 1 companies in total, including UroGen Pharma Ltd (URGN) .
Click here to see the complete history of Stephen Mullennix’s form 4 insider trades.
Insider Ownership Summary of Stephen Mullennix
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2020-04-27 | COO |
Stephen Mullennix Latest Holdings Summary
Stephen Mullennix currently owns a total of 1 stock. Stephen Mullennix owns 10,084 shares of UroGen Pharma Ltd (URGN) as of April 27, 2020, with a value of $107,596.
Latest Holdings of Stephen Mullennix
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2020-04-27 | 10,084 | 10.67 | 107,596 |
Holding Weightings of Stephen Mullennix
Stephen Mullennix Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen Mullennix has made a total of 0 transactions in UroGen Pharma Ltd (URGN) over the past 5 years. The most-recent trade in UroGen Pharma Ltd is the sale of 145 shares on April 27, 2020, which brought Stephen Mullennix around $3,531.
Insider Trading History of Stephen Mullennix
- 1
Stephen Mullennix Trading Performance
Stephen Mullennix Ownership Network
Ownership Network List of Stephen Mullennix
Ownership Network Relation of Stephen Mullennix
Stephen Mullennix Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Stephen Mullennix is the COO of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Medical Officer Mark Schoenberg , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Stephen Mullennix made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 30,141 shares made by Mark Schoenberg , and a net sale of 18,886 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 0 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 49,027 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 49,027 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Stephen Mullennix Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen Mullennix. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Stephen Mullennix's mailing address is: Ra'anana L3 4365007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
